Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
261,391
-
Share change
-
+86,065
-
Total reported value
-
$54,054,438
-
Price per share
-
$206.52
-
Number of holders
-
46
-
Value change
-
+$17,783,271
-
Number of buys
-
22
-
Number of sells
-
12
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q4 2025
As of 31 Dec 2025,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
261,391 shares.
The largest 10 holders included
Stonebridge Financial Group, LLC, Hartford Financial Management Inc., Arlington Financial Advisors, LLC, RPG Investment Advisory, LLC, Holistic Financial Partners, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Quad-Cities Investment Group, LLC, DAYMARK WEALTH PARTNERS, LLC, Nilsine Partners, LLC, and Stablepoint Partners, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.